| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 05/22/2009 | WO2009063226A2 Methods relating to breathing disorders |
| 05/22/2009 | WO2009035929A3 Cardiovascular and brain cell therapy using intracellular ryanodine receptor modulation by the estrogen receptor beta |
| 05/22/2009 | WO2008073851A3 Remotely triggered release from heatable surfaces |
| 05/21/2009 | US20090131825 Imageable biopsy site marker |
| 05/21/2009 | US20090131277 Prostate cancer diagnosis and treatment |
| 05/21/2009 | US20090130030 Plural Activating Optical Change Toothpastes, Stimuli and Elements |
| 05/21/2009 | US20090130025 Apparatus and methods for the production of ultrasound contrast agents |
| 05/21/2009 | US20090130024 Biocompatible N, N-Disubstituted Sulfonamide-Containing Fluorescent Dye Labels |
| 05/21/2009 | US20090130023 Multiple Contrast Agent Injection For Imaging |
| 05/21/2009 | US20090130021 Methods, products and uses involving platelets and/or the vasculature |
| 05/21/2009 | US20090130018 Supramolecular aggregates containing chelating agents and bioactive peptides as effective and selective delivery tools for drugs and contrast agents in mri or nuclear medicine |
| 05/20/2009 | EP2060273A2 MRI contrast medium composition for oral administration |
| 05/20/2009 | EP0885024A4 Methods for embolizing blood vessels |
| 05/20/2009 | CN201239203Y Tail suspension tester |
| 05/20/2009 | CN201239200Y Instrument for generating thrombus in small animal |
| 05/20/2009 | CN101437551A Ultrasound contrast agents for molecular imaging |
| 05/20/2009 | CN101437550A Real-time detection of influenza virus |
| 05/20/2009 | CN101437549A Method for testing drug sensitivity in solid tumors by quantifying mrna expression in thinly-sliced tumor tissue |
| 05/20/2009 | CN101437548A The staudinger reaction in imaging and therapy and kits for use in imaging and therapy |
| 05/20/2009 | CN101437547A Vectors and methods for genetic immunization |
| 05/20/2009 | CN101433726A Magnetic resonance contrast agent based on carbon nano-tube and preparation method |
| 05/20/2009 | CN101433722A Fusions of cytokines and tumor targeting proteins |
| 05/20/2009 | CN101433515A High-efficient low-toxicity ultrasonic microvesicle for carrying ricin A chain and preparation method thereof |
| 05/20/2009 | CN100488569C Liver specificity ultra micro paramagnetism MRI contrast medium |
| 05/19/2009 | US7534859 Protein kinase C epsilon as modulator of anxiety, alcohol consumption and self-administration of drugs of abuse |
| 05/19/2009 | US7534452 Multilayer insert; radiopaque element, core, shell; controlling porosity of matrix |
| 05/19/2009 | US7534437 new mutant forms of the Sm14 protein, for producing a greater production volume; providing protection against schistosome and fasciola infection |
| 05/19/2009 | US7534431 Targetting antibodies containing haptens, cleaning agent, and drug delivery agent; tissue-directed therapy; solid phase synthesis |
| 05/19/2009 | US7534419 Calibration using chaperone protein |
| 05/14/2009 | WO2009061456A2 Ultrasmall superparamagnetic iron oxide nanoparticles and uses thereof |
| 05/14/2009 | WO2009060403A2 Cest mri contrast agents based on non-spherical particles |
| 05/14/2009 | WO2009060021A1 Contrast agents |
| 05/14/2009 | WO2009042621A3 Injection system having microbubble-enhanced extravasation detection system |
| 05/14/2009 | WO2009042577A3 Injection monitor |
| 05/14/2009 | WO2008124735A3 Multi-functional polyglutamate drug carriers |
| 05/14/2009 | US20090124874 Blood Content Detecting Capsule |
| 05/14/2009 | US20090123384 Method for magnetic resonance imaging using stimulus induced rotary saturation with a contrast agent |
| 05/14/2009 | US20090123383 Non-Isotopic Detection of Osteoblastic Activity In Vivo Using Modified Bisphosphonates |
| 05/14/2009 | US20090123382 Light emitting microorganisms and cells for diagnosis and therapy of tumors |
| 05/14/2009 | US20090123381 Imaging and therapeutic targeting of prostate and bladder tissues |
| 05/14/2009 | US20090123380 instructing group of individuals to combine primarily salty tastant with primarily salty foods and primarily sweet tastant with primarily sweet foods and after testing period ends, determining whether the individuals of the group lost weight during the testing period |
| 05/14/2009 | US20090123379 Novel screens to identify agents that modulate retinal blood vessel function and pericyte function and diagnostic and therapeutic application therefor |
| 05/14/2009 | US20090123378 Uses and compositions for treatment of ankylosing spondylitis |
| 05/14/2009 | US20090123377 Method for Testing Substances or Mixtures of Substances,Use of Said Method and Corresponding Test Kits |
| 05/14/2009 | US20090123376 Therapeutic agents with decreased toxicity |
| 05/14/2009 | US20090123374 Methods for determining cancer resistance to histone deacetylase inhibitors |
| 05/14/2009 | US20090123373 Amyloid-imaging agents |
| 05/14/2009 | US20090123372 radioactively labeled high affinity CA-IX ligands that identify enzymatic activity of cell-surface expressed carbonic anhydrase-IX (CA-IX), a protein over expressed in patients in with tumor growth; sulfonamide compounds useful for in vivo positron emission tomography for the diagnosis of cancer |
| 05/14/2009 | US20090123371 Molecular signature of cancer |
| 05/14/2009 | US20090123367 Soluble Glycosaminoglycanases and Methods of Preparing and Using Soluble Glycosaminoglycanases |
| 05/14/2009 | US20090123365 Multifunctional nanostructures, methods of synthesizing thereof, and methods of use thereof |
| 05/13/2009 | EP2058007A2 Cyanine and indocyanine dye bioconjugates for biomedical applications |
| 05/13/2009 | EP2057131A1 Method of dynamic nuclear polarisation (dnp) and compounds and compositions for use in the method |
| 05/13/2009 | EP2056885A2 Contrast agent comprising a tm2+ containing luminescent substance for optical imaging |
| 05/13/2009 | EP2056884A2 Method and composition to evaluate cytochrome p450 2c19 isoenzyme activity using a breath test |
| 05/13/2009 | EP2056873A2 Methods and compositions for needleless delivery of particles |
| 05/13/2009 | EP2056834A1 Methods and compositions for increasing patient tolerability during myocardial imaging methods |
| 05/13/2009 | EP2056709A1 Dual-sensitizer-containing luminescent compounds, conjugates, and uses thereof |
| 05/13/2009 | EP1363538A4 Enhanced ultrasound detection with temperature dependent contrast agents |
| 05/13/2009 | CN101432011A Methods for regulating neurotransmitter systems by inducing counteradaptations |
| 05/13/2009 | CN101427938A Method for modeling excessive type deficiency of vital energy syndrome animal model |
| 05/13/2009 | CN100486519C Hot plate experimentation on-line automatic detection device |
| 05/12/2009 | US7531712 P450 gene regulation |
| 05/12/2009 | US7531676 Bipolar; cationic head linked to a hydrophobic backbone and a hydrophilic tail; capable of self assembly to form stable complexes in aqueous solutions; use for the delivery of bioactive substances such as nucleic acids to cells in vitro and especially in vivo |
| 05/12/2009 | US7531563 e.g. 4,5-Dihydro-2-(2,4-dihydroxyphenyl)-thiazole-4(S)-carboxylic acid; ferrochelatase; thalassemia, anemia; diagnosing and treating pathological conditions associated with excess of trivalent metals (such as Fe, Al and Cr) |
| 05/12/2009 | US7531502 Diagnostic conjugate useful for intracellular imaging and for differentiating between tumor- and non-tumor cells |
| 05/12/2009 | US7531183 Biologically active hemagglutinin from type A Clostridium botulinum and methods of use |
| 05/12/2009 | US7531164 Preventing bacterial or viral infectivity and composition containing infection preventing additive |
| 05/12/2009 | US7531163 Enrichment methods for the detection of pathogens and other microbes |
| 05/12/2009 | US7530940 Methods of enhancing radiation effects with metal nanoparticles |
| 05/12/2009 | US7530461 Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy |
| 05/07/2009 | WO2009059215A1 Use of fullerenes in photoacoustic imaging |
| 05/07/2009 | WO2009057021A2 Photoacoustic imaging contrast agent and system for converting optical energy to in-band acoustic emission |
| 05/07/2009 | WO2009056555A1 Contrast agents |
| 05/07/2009 | WO2009055937A1 Altered n-cadherin processing in tumor cells by furln and proproteln convertase 5a (pc5a) |
| 05/07/2009 | WO2009032160A3 Metalloprotein mri contrast agents and related methods |
| 05/07/2009 | WO2009018335A9 Targeting brain cells via ophtalmic delivery |
| 05/07/2009 | WO2009012288A3 Trifunctional imaging agent for monoclonal antibody tumor-targeted imaging |
| 05/07/2009 | WO2008085564A3 Compositions and methods involving truncated recombinant seven g-protein coupled receptors |
| 05/07/2009 | WO2008073856A3 Delivery of nanoparticles and/or agents to cells |
| 05/07/2009 | WO2008060669A3 Vaccine for avian influenza and methods of use |
| 05/07/2009 | WO2007100357A3 Stem cell factor-like protein scfa1 and uses thereof |
| 05/07/2009 | WO2007098020A3 Methods of screening patients for omega-3 fatty acid therapy |
| 05/07/2009 | WO2007056039A3 Therapies for seizure disorders using rlip76 |
| 05/07/2009 | WO2007019415A3 Specific bacterial inclusions in bone marrow cells indicate systematic lupus erythematosus, and treatment for lupus |
| 05/07/2009 | US20090118579 Medical capsule |
| 05/07/2009 | US20090117053 Local delivery of 5-aminolevulinic-acid based compounds to tissues and organs for diagnostic and therapeutic purposes |
| 05/07/2009 | US20090117051 Uridine dietary supplementation compliance methods and use thereof |
| 05/07/2009 | US20090117049 Light emitting microorganisms and cells for diagnosis and therapy of tumors |
| 05/07/2009 | US20090117048 Light emitting microorganisms and cells for diagnosis and therapy of tumors |
| 05/07/2009 | US20090117047 Light emitting microorganisms and cells for diagnosis and therapy of tumors |
| 05/07/2009 | US20090117046 Methods for evaluating genetic susceptibility and therapy for chronic inflammatory diseases |
| 05/07/2009 | US20090117045 Soy or lentil stabilized gold nanoparticles and method for making same |
| 05/07/2009 | US20090117044 Method for quantifying the uptake of at least one radiotracer in a body region of a patient of interest to a positron emission tomography measurement |
| 05/07/2009 | US20090117043 Antibodies That Specifically Bind to Neurokinin B |
| 05/07/2009 | US20090117040 Novel pharmaceutical and diagnostic compositions for use in the treatment and diagnosis of neurodegenerative diseases or amyloid diseases |
| 05/07/2009 | US20090117035 Temperature-Sensitive Liposomal Formulation |
| 05/07/2009 | US20090117034 Microorganisms for imaging and/or treatment of tumors |
| 05/07/2009 | US20090115415 System and method for use of nanoparticles in imaging and temperature measurement |
| 05/07/2009 | CA2740310A1 Altered cadherin processing in tumor cells |